Report: Prescription Drug Spending Climbs in 2013

Total U.S. prescription drug spending climbed more than 3% last year, propelled in part by fewer patent expirations that would have allowed for cheaper generic alternatives, according to the data firm IMS Health.

Prescription spending reached $329.2 billion in 2013 after declining 1% the year before. IMS health said price hikes, expensive new drugs and greater use of the health care system also led to the spending rise, which it detailed in a report Tuesday.

Fewer patent expirations, however, were the largest factor. The expiration of U.S. patents protecting blockbuster drugs like the cholesterol fighter Lipitor has led to a spike in generic drug use in recent years, but that wave is starting to wane.

IMS Health also noted that 36 new treatments entered the market last year, including 10 for cancer. That also includes drugs for hepatitis C, multiple sclerosis and diabetes.

New, innovative drugs often come with high price tags, like the $1,000-a-pill price set by drugmaker Gilead Sciences for its hepatitis C treatment Sovaldi.

Drugmakers have said the high cost of treatments like Sovaldi can be recouped over time, as fewer patients suffer expensive complications for their conditions.

IMS Health also said price hikes for branded drugs added more than $4 billion in spending growth last year, and the overall spending per person rose about 1%.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2916702, ~/Articles/ArticleHandler.aspx, 12/21/2014 8:22:29 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Apple's next smart device (warning, it may shock you

Apple recently recruited a secret-development "dream team" to guarantee its newest smart device was kept hidden from the public for as long as possible. But the secret is out. In fact, ABI Research predicts 485 million of this type of device will be sold per year. But one small company makes Apple's gadget possible. And its stock price has nearly unlimited room to run for early-in-the-know investors. To be one of them, and see Apple's newest smart gizmo, just click here!


Advertisement